Get the Stockscreener App
4.44
2.30%
0.10
Lantern Pharma Inc stock is traded at $4.44, with a volume of 70,865.
It is up +2.30% in the last 24 hours and up +15.93% over the past month.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
See More
Previous Close:
$4.34
Open:
$4.43
24h Volume:
70,865
Relative Volume:
0.43
Market Cap:
$47.79M
Revenue:
-
Net Income/Loss:
$-19.25M
P/E Ratio:
-2.4944
EPS:
-1.78
Net Cash Flow:
$-17.87M
1W Performance:
+0.91%
1M Performance:
+15.93%
6M Performance:
+38.32%
1Y Performance:
+27.59%
1-Day Range:
$4.30
$4.5257
1-Week Range:
$4.27
$4.7034
52-Week Range:
$2.55
$6.118
Lantern Pharma Inc Stock (LTRN) Company Profile
Name
Lantern Pharma Inc
Sector
Industry
Phone
972-277-1136
Address
1920 MCKINNEY AVENUE, DALLAS, TX
Compare LTRN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
4.425 | 46.87M | 0 | -19.25M | -17.87M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.62 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.57 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.99 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
803.71 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.86 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-21 | Initiated | H.C. Wainwright | Buy |
Lantern Pharma Inc Stock (LTRN) Latest News
Using economic indicators to assess Lantern Pharma Inc. potentialWeekly Stock Summary & Weekly High Potential Alerts - newser.com
When is the best time to exit Lantern Pharma Inc.Entry Point & Long-Term Safe Investment Plans - newser.com
Is Lantern Pharma Inc. stock a buy before product launchesQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Will Lantern Pharma Inc. stock recover after recent drop2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
How to build a custom watchlist for Lantern Pharma Inc.Weekly Profit Analysis & Real-Time Chart Pattern Alerts - newser.com
Has Lantern Pharma Inc. formed a bullish divergenceWeekly Stock Analysis & Verified Chart Pattern Signals - newser.com
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Petoskey News-Review
Lantern Pharma (NASDAQ:LTRN) Trading Down 6.1% – Here’s What Happened - Defense World
Lantern Pharma (NASDAQ:LTRN) Rating Increased to Hold at Wall Street Zen - Defense World
Can momentum traders help lift Lantern Pharma Inc.Market Sentiment Review & Comprehensive Market Scan Reports - newser.com
Technical analysis overview for Lantern Pharma Inc. stock2025 Earnings Impact & Technical Entry and Exit Tips - newser.com
Visual analytics tools that track Lantern Pharma Inc. performanceJuly 2025 Snapshot & Capital Efficient Trading Techniques - newser.com
Why Lantern Pharma Inc. is moving todayMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Trend analysis for Lantern Pharma Inc. this weekShort Setup & Weekly High Conviction Trade Ideas - newser.com
Using flow based indicators on Lantern Pharma Inc.July 2025 Summary & Real-Time Volume Triggers - newser.com
Is Lantern Pharma Inc. stock a buy for dividend growthJuly 2025 Movers & Real-Time Volume Analysis - newser.com
What’s the recovery path for long term holders of Lantern Pharma Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Lantern Pharma Inc. stock prediction for this weekEarnings Trend Report & Daily Profit Maximizing Tips - newser.com
Is Lantern Pharma Inc. showing signs of accumulation2025 Market Outlook & Verified Short-Term Trading Plans - newser.com
Lantern Pharma Inc.’s volatility index tracking explainedJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
What analysts say about Lantern Pharma Inc stockBullish Engulfing Patterns & Backtest Your Strategy Before You Risk Money - earlytimes.in
Is Lantern Pharma Inc a good long term investmentDividend Aristocrats List & Affordable Portfolio Building - earlytimes.in
FDA Guidance Advances Lantern Pharma's Pediatric Brain Cancer Therapy Toward 2026 Clinical Trial - citybuzz
Lantern Pharma Inc Stock (LTRN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lantern Pharma Inc Stock (LTRN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kreis Leslie W. | 10% Owner |
Jun 13 '25 |
Sale |
3.09 |
40,000 |
123,600 |
49,957 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Kreis Leslie W. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Kreis Leslie W. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Kreis Leslie W. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Fletcher Aaron G.L. | 10% Owner |
May 27 '25 |
Sale |
3.05 |
21,037 |
64,163 |
56,467 |
| Fletcher Aaron G.L. | 10% Owner |
May 29 '25 |
Sale |
3.03 |
20,200 |
61,206 |
54,792 |
| Fletcher Aaron G.L. | 10% Owner |
May 28 '25 |
Sale |
2.87 |
15,000 |
43,050 |
55,753 |
1.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):